SBIR/STTR Research Award

Safe, Low-Cost Anesthesia Using Recycled Xenon Gas

Award identifier ba417d5f9af75fd215551377b3122df796b41c3668b3397381f653ddb5003341Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$99,910

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
CREARE LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
JDKYAKDT4TT6
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (Verbatim from the Applicant's Abstract): Xenon gas is a very attractive anesthetic agent because of its minimal effects on the cardiovascular system and rapid induction and emergence. However, xenon is used only rarely because of its high cost compared to common inhaled anesthetic agents. Even if it were not so costly, the limited supply of xenon would greatly restrict its use as an anesthetic. The long-term objective of this application is to make xenon anesthesia available for widespread use at low cost. The specific aim is to develop processes and devices to recycle xenon gas by collecting waste gases from anesthesia procedures, then separating and purifying the xenon for re-use. Phase I proves feasibility by (1) demonstrating the key process steps required to separate xenon from typical anesthetic waste gas, (2) producing conceptual designs for all devices needed to accomplish xenon recovery, and (3) showing by analysis that the cost of recycled xenon will be competitive with common inhaled anesthetic agents. PROPOSED COMMERCIAL APPLICATION: Low-cost xenon anesthetic gas will be attractive for two broad applications: (1) xenon gas will be the anesthetic agent of choice for a large fraction of the millions of surgical procedures that are performed each year in the United States on patients with cardiovascular conditions; and (2) because of fewer complications and rapid induction and emergence, xenon anesthesia can reduce patient time in the hospital, with large benefits to health care costs. The proposed research will lead directly to processes and devices that will provide a low-cost source of xenon for these widespread applications.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

1,365 SBIR/STTR records share this UEI (1983–2026). Reported award amounts total $507,020,394. Reported amounts are not federal obligations.

Phases: Phase I, Phase II, Phase II – Direct to Phase II

Agencies: Department of Defense, National Aeronautics and Space Administration, Department of Health and Human Services, Department of Energy, Department of Transportation, Department of Commerce

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.